Covey D C, Albright J A
Department of Orthopaedic Surgery, Louisiana State University School of Medicine, Shreveport.
Orthop Rev. 1989 Aug;18(8):857-63.
Treatment of orthopaedic lesions through induction of bone regeneration has produced promising results in laboratory animals and preliminary human trials. Both demineralized bone powder and bone morphogenetic protein (BMP) are being used clinically to treat bony defects without the need for an autogenous bone harvesting procedure. The historical perspective and laboratory rationale for osteoinduction is presented, as well as current and future clinical applications of demineralized bone powder and BMP.
通过诱导骨再生来治疗骨科损伤,已在实验动物和初步人体试验中取得了有前景的结果。脱矿骨粉和骨形态发生蛋白(BMP)目前都在临床上用于治疗骨缺损,而无需进行自体骨采集手术。本文介绍了骨诱导的历史背景和实验室理论依据,以及脱矿骨粉和BMP目前及未来的临床应用情况。